Targeting of tumor endothelial cells combining 2 Gy/day of X‐ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors

Yoshikazu Kuwahara(Tohoku University)
Cancer Medicine
January 27, 2014
Cited by 38


Related Papers